MyFinsight
Home
About
Contact
kymr: the income statement
Download
Download image
Total comprehensive
loss
-$80,953K
(-38.48%↓ Y/Y)
Unrealized gain on
marketable securities
$1,222K
(-69.68%↓ Y/Y)
Interest and other income
$10,444K
(7.70%↑ Y/Y)
Net loss
-$82,175K
(-31.51%↓ Y/Y)
Total other income
$10,346K
(7.36%↑ Y/Y)
Interest and other
expense
$98K
(63.33%↑ Y/Y)
Loss from operations
-$92,521K
(-28.28%↓ Y/Y)
Collaboration revenue
$2,764K
(-26.12%↓ Y/Y)
Total operating
expenses
$95,285K
(25.60%↑ Y/Y)
Impairment of long-lived
assets
$3,855K
General and
administrative
$17,336K
(12.17%↑ Y/Y)
Research and development
$74,094K
(22.65%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR)